Glucagon-like peptide-1 prevents β-cells glucolipotoxicity in human islets and INS832/13 cells

被引:0
|
作者
Buteau, J
El-Assaad, W
Rhodes, C
Rosenberg, L
Joly, E
Prentki, M
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A352 / A352
页数:1
相关论文
共 50 条
  • [1] β-Arrestin1-mediated recruitment of c-Src underlies the proliferative action of glucagon-like peptide-1 in pancreatic β INS832/13 cells
    Talbot, Jason
    Joly, Erik
    Prentki, Marc
    Buteau, Jean
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 364 (1-2) : 65 - 70
  • [2] Glucagon-like peptide-1 prevents beta cell glucolipotoxicity
    J. Buteau
    W. El-Assaad
    C. J. Rhodes
    L. Rosenberg
    E. Joly
    M. Prentki
    Diabetologia, 2004, 47 : 806 - 815
  • [3] Glucagon-like peptide-1 prevents beta cell glucolipotoxicity
    Buteau, J
    El-Assaad, W
    Rhodes, CJ
    Rosenberg, L
    Joly, E
    Prentki, M
    DIABETOLOGIA, 2004, 47 (05) : 806 - 815
  • [4] Glucagon-Like Peptide-1 and Candesartan Additively Improve Glucolipotoxicity in Pancreatic β-Cells
    Ueno, Hiroaki
    Wang, Hong-Wei
    Mizuta, Masanari
    Noma, Kenji
    Saitoh, Yukie
    Nakazato, Masamitsu
    DIABETES, 2011, 60 : A703 - A703
  • [5] Glucagon-like peptide-1 and candesartan additively improve glucolipotoxicity in pancreatic β-cells
    Wang, Hong-Wei
    Mizuta, Masanari
    Saitoh, Yukie
    Noma, Kenji
    Ueno, Hiroaki
    Nakazato, Masamitsu
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (08): : 1081 - 1089
  • [6] Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes
    Campbell, Scott A.
    Golec, Dominic P.
    Hubert, Matt
    Johnson, Janyne
    Salamon, Nicole
    Barr, Amy
    MacDonald, Patrick E.
    Philippaert, Koenraad
    Light, Peter E.
    MOLECULAR METABOLISM, 2020, 39
  • [7] Microarray analysis of human islets of Langerhans treated with glucagon-like peptide-1
    Nolan, A
    Lechner, A
    Habener, J
    DIABETES, 2003, 52 : A245 - A245
  • [8] Peptide sensing by glucagon-like peptide-1 secreting L cells
    Diakogiannaki, E.
    Pais, R.
    Parker, H.
    Tolhurst, G.
    Ramzan, A.
    Horscroft, J.
    Daniel, H.
    Gribble, F.
    Reimann, F.
    DIABETOLOGIA, 2013, 56 : S265 - S265
  • [9] Neuroprotective actions of Glucagon-like peptide-1 in differentiated human neuroprogenitor cells
    Velmurugan, Kalpana
    Bouchard, Ron
    Mahaffey, Gregory
    Pugazhenthi, Subbiah
    JOURNAL OF NEUROCHEMISTRY, 2012, 123 (06) : 919 - 931
  • [10] Glucagon and glucagon-like peptide-1
    Livingston, JN
    Schoen, WR
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34, 1999, 34 : 189 - 198